REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Excelsior Biopharma Inc. (Taiwan, China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Excelsior Biopharma Inc. Profile Updated: February 22, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Chinese Download a sample report

Excelsior Biopharma Inc.specializes in medical pharmacy. The company's main business items: prescription drugs, general health products, medical beauty products, etc. Excelsior Biopharma was established in 1988 and located in Taipei City.

Headquarters
14F-6, No.3, Park St., Nangang Dist
Taipei City; Taipei City;

Contact Details: Purchase the Excelsior Biopharma Inc. report to view the information.

Website: http://www.excelsiorgroup.com.tw

Basic Information
Total Employees:
Purchase the Excelsior Biopharma Inc. report to view the information.
Outstanding Shares:
Purchase the Excelsior Biopharma Inc. report to view the information.
Financial Auditors:
Purchase the Excelsior Biopharma Inc. report to view the information.
Incorporation Date:
July 21, 1988
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Manager
Ownership Details
Purchase this report to view the information.
21.23%
Purchase this report to view the information.
13.86%
Purchase this report to view the information.
1.08%
Purchase this report to view the information.
0.52%
Purchase this report to view the information.
0.46%
Subsidiaries
Excelsior Pharmatech Labs.
100%
EirGenix Inc.
0.19%
Company Performance
Financial values in the chart are available after Excelsior Biopharma Inc. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TWD. Absolute financial data is included in the purchased report.
Net sales revenue
11.48%▲
Total operating revenue
11.63%▲
Operating profit (EBIT)
-184.75%▼
EBITDA
-859.68%▼
Net Profit (Loss) for the Period
-198.11%▼
Total assets
12.54%▲
Total equity
-8.25%▼
Operating Profit Margin (ROS)
-9.24%▼
Net Profit Margin
-10.82%▼
Return on Equity (ROE)
-6.14%▼
Quick Ratio
-0.5%▼
Cash Ratio
-0.09%▼

Similar companies

Lotus Pharmaceutical Co., Ltd.
 
Great Tree Pharmacy Co.,Ltd.
Bora Pharmaceuticals Co., Ltd.
 
China Chemical & Pharmaceutical Co., Ltd
Pharmally International Holding Co., Ltd
 
Taiwan Biotech Co., Ltd.
PharmaEngine, Inc.
 
GeneFerm Biotechnology Co., Ltd.
UBI Pharma Inc.
 
Winston Medical Supply Co., Ltd.
Maxigen Biotech Inc.
 

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo